Endotoxin Contamination Risk Prompts Recall of Centric Compounding Vials

Fever, chills, chest pain, and in the worst cases, anaphylactic shock or death — these are the dangers now tied to a nationwide recall of injectable wellness products made by a Houston-based compounding pharmacy. If you or someone you know has received Glutathione, Myer’s Cocktail, or Tri-Immune Boost injections in recent months, it is worth checking the lot number on the vial right away.

Centric Compounding LLC announced on September 11, 2026 that it is voluntarily recalling six lots of its compounded Glutathione 200mg/mL, Myer’s Cocktail, and Tri-Immune Boost products, all packaged as 30mL multidose vials. The recall, posted publicly by the U.S. Food and Drug Administration on September 13, was triggered after the company determined the products were compounded using a Glutathione active pharmaceutical ingredient (API) that contained elevated endotoxin levels.

Why Was This Recall Issued?

Endotoxins are toxic substances that can be released by certain bacteria. When present in injectable drugs at elevated levels, they pose a serious health threat because they enter the bloodstream directly, bypassing the body’s normal defenses against ingested contaminants. According to Centric Compounding, there is a reasonable probability that injectable products contaminated in this way could cause significant medical events, including fevers, hypotension, inflammatory reactions, anaphylactic shock, and death.

The company has already received nine reports of adverse reactions linked to the affected products, including fever, chills, chest pain, nausea and vomiting, headache, and general malaise.

Products Affected by This Recall

The recalled products are marketed to support immunity, fatigue, and general wellness, and were distributed nationwide directly to patients through home delivery as well as to prescribers for in-office administration. The specific lots involved are listed below.

• Glutathione 200mg/mL 30mL vial — Lot 062326:B, Beyond Use Date 8/7/26
• Glutathione 200mg/mL 30mL vial — Lot 070826:A, Beyond Use Date 8/22/26
• Glutathione 200mg/mL 30mL vial — Lot 072726:D, Beyond Use Date 9/25/26
• Myer’s Cocktail 30mL vial — Lot 070226:D, Beyond Use Date 8/16/26
• Myer’s Cocktail 30mL vial — Lot 072126:A, Beyond Use Date 9/4/26
• Tri-Immune Boost 30mL vial — Lot 071626:B, Beyond Use Date 8/30/26

Who Is Affected?

Because these products were shipped nationwide to both individual consumers and prescribing healthcare providers, the recall’s reach is broad. Anyone who received one of these injectable vials for home use, or who was administered a dose at a clinic or provider’s office, could be affected. Patients who cannot confirm whether their product came from an unaffected lot are advised to treat it as recalled out of caution.

What Should You Do?

Consumers who have any of the affected Glutathione, Myer’s Cocktail, or Tri-Immune Boost vials at home should stop using them immediately and discard the product. Centric Compounding says it is notifying its distributors and customers by email and is arranging for replacement of all recalled vials at no cost.

Anyone who has experienced fever, chills, chest pain, nausea, vomiting, headache, or malaise after using one of these products should contact their physician or healthcare provider promptly. Adverse reactions or quality issues can also be reported to the FDA’s MedWatch Adverse Event Reporting program online, by mail, or by fax.

Consumers with questions about the recall can reach Centric Compounding by phone at 833-777-6664 or by email at info@centriccompounding.com, Monday through Friday from 9am to 5pm CST.

Official Statement

In its announcement, Centric Compounding stated that the products ‘have been found to be compounded with a Glutathione API containing elevated endotoxin levels,’ and confirmed that ‘this recall is being conducted with the knowledge of the U.S. Food and Drug Administration.’ The FDA posted the company’s announcement as a public service and does not endorse the product or the company.

Quick Facts:

• 6 lots recalled across three products
• Distributed nationwide via home delivery and prescriber delivery
• 9 adverse event reports received so far
• Company announcement date: September 11, 2026